Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alnylam Pharmaceuticals, Inc. (ALNY) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alnylam Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1178670.
Total stock buying since 2014: $1,938,056,444.
Total stock sales since 2014: $464,736,445.
Total stock option exercises since 2014: $115,454,760.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 220,867 | $72,982,383 | 192,050 | $19,901,314 |
| 2024 | 0 | $0 | 180,137 | $41,538,738 | 151,030 | $11,355,349 |
| 2023 | 0 | $0 | 100,675 | $19,776,163 | 68,357 | $3,375,750 |
| 2022 | 0 | $0 | 121,519 | $26,219,683 | 121,196 | $6,550,509 |
| 2021 | 0 | $0 | 268,501 | $46,604,850 | 260,889 | $10,065,554 |
| 2020 | 0 | $0 | 627,192 | $86,811,603 | 608,710 | $21,285,941 |
| 2019 | 0 | $0 | 271,230 | $23,808,965 | 271,230 | $4,648,071 |
| 2018 | 0 | $0 | 336,545 | $45,286,903 | 389,257 | $12,575,964 |
| 2017 | 309,001 | $22,132,898 | 518,586 | $55,428,350 | 546,527 | $16,310,615 |
| 2016 | 234,930 | $15,449,889 | 119,619 | $7,505,502 | 183,397 | $3,818,292 |
| 2015 | 953,817 | $1,900,473,657 | 345,920 | $38,773,305 | 376,041 | $5,295,571 |
| 2014 | 0 | $0 | 0 | $0 | 17,000 | $271,830 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-11 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 758 | 154.00 | 116,732 |
| 2020-12-18 | Paul Steven M (Director) | Sale | 15,000 | 140.00 | 2,100,000 |
| 2020-12-18 | Paul Steven M (Director) | Option Ex | 15,000 | 9.30 | 139,500 |
| 2020-11-25 | Sharp Phillip A (Director) | Sale | 30,000 | 125.74 | 3,772,140 |
| 2020-11-25 | Sharp Phillip A (Director) | Option Ex | 30,000 | 9.30 | 279,000 |
| 2020-11-19 | Maraganore John (Chief Executive Officer) | Sale | 34,765 | 125.00 | 4,345,729 |
| 2020-11-19 | Maraganore John (Chief Executive Officer) | Option Ex | 34,765 | 9.14 | 317,752 |
| 2020-09-29 | Vaishnaw Akshay (President, R&D) | Sale | 971 | 140.00 | 135,940 |
| 2020-09-29 | Vaishnaw Akshay (President, R&D) | Option Ex | 971 | 42.22 | 40,995 |
| 2020-09-09 | Greene Barry E (President) | Sale | 44,530 | 123.48 | 5,498,430 |
| 2020-09-09 | Greene Barry E (President) | Option Ex | 44,530 | 9.14 | 407,004 |
| 2020-08-20 | Maraganore John (Chief Executive Officer) | Sale | 34,765 | 136.01 | 4,728,283 |
| 2020-08-20 | Maraganore John (Chief Executive Officer) | Option Ex | 34,765 | 9.14 | 317,752 |
| 2020-08-10 | Greene Barry E (President) | Option Ex | 4,931 | 72.66 | 358,261 |
| 2020-07-13 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 47,250 | 159.79 | 7,549,983 |
| 2020-07-13 | Keating Laurie (EVP, Chief Legal Officer) | Option Ex | 35,750 | 89.47 | 3,198,552 |
| 2020-07-10 | Greenstreet Yvonne (Chief Operating Officer) | Sale | 46,639 | 161.00 | 7,508,879 |
| 2020-07-10 | Greenstreet Yvonne (Chief Operating Officer) | Option Ex | 46,639 | 77.10 | 3,595,866 |
| 2020-07-09 | Greenstreet Yvonne (Chief Operating Officer) | Sale | 11,236 | 161.00 | 1,808,996 |
| 2020-07-09 | Greenstreet Yvonne (Chief Operating Officer) | Option Ex | 11,236 | 59.66 | 670,339 |
| 2020-07-07 | Greene Barry E (President) | Sale | 22,265 | 159.99 | 3,562,177 |
| 2020-07-07 | Greene Barry E (President) | Option Ex | 22,265 | 9.14 | 203,502 |
| 2020-06-22 | Vaishnaw Akshay (President, R&D) | Sale | 970 | 150.62 | 146,101 |
| 2020-06-22 | Vaishnaw Akshay (President, R&D) | Option Ex | 970 | 42.22 | 40,953 |
| 2020-05-20 | Maraganore John (Chief Executive Officer) | Sale | 34,765 | 143.43 | 4,986,448 |
| 2020-05-20 | Maraganore John (Chief Executive Officer) | Option Ex | 34,765 | 9.14 | 317,752 |
| 2020-05-06 | Greenstreet Yvonne (Chief Operating Officer) | Sale | 50,000 | 150.00 | 7,500,000 |
| 2020-05-06 | Greenstreet Yvonne (Chief Operating Officer) | Option Ex | 50,000 | 77.10 | 3,854,999 |
| 2020-05-06 | Greene Barry E (President) | Sale | 22,265 | 149.99 | 3,339,527 |
| 2020-05-06 | Greene Barry E (President) | Option Ex | 22,265 | 9.14 | 203,502 |
| 2020-05-05 | Greenstreet Yvonne (Chief Operating Officer) | Sale | 7,811 | 140.00 | 1,093,540 |
| 2020-05-05 | Greenstreet Yvonne (Chief Operating Officer) | Option Ex | 7,811 | 42.22 | 329,780 |
| 2020-04-20 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 10,000 | 139.00 | 1,390,000 |
| 2020-04-20 | Keating Laurie (EVP, Chief Legal Officer) | Option Ex | 10,000 | 77.40 | 774,000 |
| 2020-04-20 | Vaishnaw Akshay (President, R&D) | Sale | 21,971 | 140.00 | 3,075,940 |
| 2020-04-20 | Vaishnaw Akshay (President, R&D) | Option Ex | 21,971 | 42.22 | 927,615 |
| 2020-02-20 | Maraganore John (Chief Executive Officer) | Sale | 34,765 | 131.14 | 4,559,186 |
| 2020-02-20 | Maraganore John (Chief Executive Officer) | Option Ex | 34,765 | 9.14 | 317,752 |
| 2020-02-12 | Sharp Phillip A (Director) | Sale | 30,000 | 130.00 | 3,900,000 |
| 2020-02-12 | Sharp Phillip A (Director) | Option Ex | 30,000 | 12.48 | 374,400 |
| 2020-02-10 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 10,000 | 129.00 | 1,290,000 |
| 2020-02-10 | Keating Laurie (EVP, Chief Legal Officer) | Option Ex | 10,000 | 77.40 | 774,000 |
| 2020-02-10 | Greenstreet Yvonne (Chief Operating Officer) | Sale | 9,892 | 130.00 | 1,285,960 |
| 2020-02-10 | Greenstreet Yvonne (Chief Operating Officer) | Option Ex | 5,600 | 42.22 | 236,432 |
| 2020-02-10 | Paul Steven M (Director) | Sale | 30,000 | 130.00 | 3,900,000 |
| 2020-02-10 | Paul Steven M (Director) | Option Ex | 30,000 | 14.67 | 440,100 |
| 2020-02-07 | Vaishnaw Akshay (President, R&D) | Sale | 23,708 | 125.00 | 2,963,500 |
| 2020-02-07 | Vaishnaw Akshay (President, R&D) | Option Ex | 22,750 | 42.22 | 960,505 |
| 2020-02-07 | Greenstreet Yvonne (Chief Operating Officer) | Sale | 6,250 | 123.90 | 774,375 |
| 2020-02-07 | Greenstreet Yvonne (Chief Operating Officer) | Option Ex | 6,250 | 42.22 | 263,875 |
| 2020-01-29 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 6,337 | 119.00 | 754,103 |
| 2020-01-29 | Keating Laurie (EVP, Chief Legal Officer) | Option Ex | 6,337 | 77.40 | 490,483 |
| 2020-01-27 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 41,037 | 118.00 | 4,842,366 |
| 2020-01-27 | Keating Laurie (EVP, Chief Legal Officer) | Option Ex | 34,374 | 42.22 | 1,451,270 |
| 2019-11-20 | Greenstreet Yvonne (Chief Operating Officer) | Sale | 8,404 | 105.00 | 882,420 |
| 2019-11-20 | Greenstreet Yvonne (Chief Operating Officer) | Option Ex | 8,404 | 42.22 | 354,816 |
| 2019-11-20 | Fanucci Marsha (Director) | Sale | 75,000 | 100.00 | 7,500,000 |
| 2019-11-20 | Fanucci Marsha (Director) | Option Ex | 75,000 | 14.96 | 1,122,375 |
| 2019-11-18 | Sharp Phillip A (Director) | Sale | 15,000 | 91.93 | 1,378,995 |
| 2019-11-18 | Sharp Phillip A (Director) | Option Ex | 15,000 | 16.43 | 246,450 |
| 2019-10-22 | Greene Barry E (President) | Sale | 58,913 | 89.99 | 5,301,580 |
| 2019-10-22 | Greene Barry E (President) | Option Ex | 58,913 | 16.43 | 967,940 |
| 2019-10-14 | Maraganore John (Chief Executive Officer) | Sale | 49,456 | 79.68 | 3,940,505 |
| 2019-10-14 | Maraganore John (Chief Executive Officer) | Option Ex | 49,456 | 16.43 | 812,562 |
| 2019-05-15 | Maraganore John (Chief Executive Officer) | Sale | 49,457 | 70.00 | 3,461,990 |
| 2019-05-15 | Maraganore John (Chief Executive Officer) | Option Ex | 49,457 | 16.43 | 812,578 |
| 2019-04-15 | Sharp Philip A (Director) | Sale | 15,000 | 89.56 | 1,343,475 |
| 2019-04-15 | Sharp Philip A (Director) | Option Ex | 15,000 | 22.09 | 331,350 |
| 2018-11-21 | Maraganore John (Chief Executive Officer) | Option Ex | 98,636 | 21.35 | 2,105,878 |
| 2018-08-30 | Greenstreet Yvonne (EVP, Chief Operating Officer) | Sale | 2,500 | 120.00 | 300,000 |
| 2018-07-25 | Maraganore John (Chief Executive Officer) | Sale | 50,000 | 104.62 | 5,231,100 |
| 2018-07-25 | Maraganore John (Chief Executive Officer) | Option Ex | 50,000 | 21.35 | 1,067,500 |
| 2018-06-20 | Keating Laurie (SVP, GC & Secretary) | Sale | 1,563 | 105.04 | 164,177 |
| 2018-06-20 | Keating Laurie (SVP, GC & Secretary) | Option Ex | 1,563 | 42.22 | 65,989 |
| 2018-05-31 | Clarke John K (Director) | Sale | 15,000 | 100.76 | 1,511,430 |
| 2018-05-31 | Clarke John K (Director) | Option Ex | 15,000 | 27.28 | 409,200 |
| 2018-03-26 | Greenstreet Yvonne (EVP, Chief Operating Officer) | Sale | 7,221 | 138.09 | 997,111 |
| 2018-03-26 | Greenstreet Yvonne (EVP, Chief Operating Officer) | Option Ex | 7,221 | 42.22 | 304,870 |
| 2018-03-20 | Keating Laurie (SVP, GC & Secretary) | Sale | 1,562 | 149.68 | 233,797 |
| 2018-03-20 | Keating Laurie (SVP, GC & Secretary) | Option Ex | 1,562 | 42.22 | 65,947 |
| 2018-03-14 | Vaishnaw Akshay (President, R&D) | Sale | 88,554 | 143.00 | 12,662,779 |
| 2018-03-14 | Vaishnaw Akshay (President, R&D) | Option Ex | 88,554 | 14.06 | 1,245,334 |
| 2018-03-14 | Greene Barry E (President) | Sale | 38,460 | 143.09 | 5,503,049 |
| 2018-03-13 | Keating Laurie (SVP, GC & Secretary) | Sale | 10,000 | 150.00 | 1,500,000 |
| 2018-03-13 | Keating Laurie (SVP, GC & Secretary) | Option Ex | 10,000 | 77.40 | 774,000 |
| 2018-03-13 | Ausiello Dennis A (Director) | Sale | 17,117 | 150.00 | 2,567,550 |
| 2018-03-13 | Ausiello Dennis A (Director) | Option Ex | 17,117 | 61.55 | 1,053,636 |
| 2018-03-13 | Schimmel Paul (Director) | Sale | 27,823 | 150.00 | 4,173,450 |
| 2018-03-13 | Schimmel Paul (Director) | Option Ex | 27,823 | 51.07 | 1,420,837 |
| 2018-03-13 | Sharp Philip A (Director) | Sale | 15,000 | 149.00 | 2,235,000 |
| 2018-03-13 | Sharp Philip A (Director) | Option Ex | 15,000 | 21.35 | 320,250 |
| 2018-03-12 | Keating Laurie (SVP, GC & Secretary) | Sale | 10,000 | 140.00 | 1,400,000 |
| 2018-03-12 | Keating Laurie (SVP, GC & Secretary) | Option Ex | 10,000 | 77.40 | 774,000 |
| 2018-03-09 | Sharp Philip A (Director) | Sale | 15,000 | 129.00 | 1,935,000 |
| 2018-03-09 | Sharp Philip A (Director) | Option Ex | 15,000 | 27.28 | 409,200 |
| 2018-01-04 | Mason Michael (VP, Finance and Treasurer) | Sale | 36,745 | 132.60 | 4,872,460 |
| 2018-01-04 | Mason Michael (VP, Finance and Treasurer) | Option Ex | 31,781 | 80.53 | 2,559,323 |
| 2017-12-30 | Mason Michael (VP, Finance and Treasurer) | Option Ex | 8,502 | .00 | 0 |
| 2017-12-29 | Keating Laurie (SVP, GC & Secretary) | Option Ex | 3,000 | 77.40 | 232,200 |
| 2017-12-20 | Keating Laurie (SVP, GC & Secretary) | Sale | 6,249 | 121.70 | 760,484 |
| 2017-12-20 | Keating Laurie (SVP, GC & Secretary) | Option Ex | 6,249 | 42.22 | 263,832 |
| 2017-12-19 | Maraganore John (Chief Executive Officer) | Option Ex | 1,587 | 63.00 | 99,981 |
| 2017-12-01 | Keating Laurie (SVP, GC and Secretary) | Sale | 30,000 | 135.46 | 4,063,859 |
| 2017-12-01 | Keating Laurie (SVP, GC and Secretary) | Option Ex | 30,000 | 77.40 | 2,322,000 |
| 2017-11-22 | Maraganore John (Chief Executive Officer) | Sale | 73,415 | 131.35 | 9,643,060 |
| 2017-11-22 | Maraganore John (Chief Executive Officer) | Option Ex | 73,415 | 31.39 | 2,304,496 |
| 2017-11-15 | Maraganore John (Chief Executive Officer) | Sale | 74,000 | 127.99 | 9,471,482 |
| 2017-11-15 | Maraganore John (Chief Executive Officer) | Option Ex | 74,000 | 31.39 | 2,322,860 |
| 2017-11-02 | Ausiello Dennis A (Director) | Sale | 20,000 | 130.00 | 2,600,000 |
| 2017-11-02 | Ausiello Dennis A (Director) | Option Ex | 20,000 | 30.09 | 601,800 |
| 2017-10-30 | Vaishnaw Akshay (EVP, R&D) | Sale | 33,666 | 121.26 | 4,082,440 |
| 2017-10-30 | Vaishnaw Akshay (EVP, R&D) | Option Ex | 33,666 | 21.35 | 718,769 |
| 2017-10-02 | Greene Barry E (President) | Sale | 85,316 | 125.00 | 10,664,500 |
| 2017-10-02 | Greene Barry E (President) | Option Ex | 85,316 | 21.35 | 1,821,496 |
| 2017-09-21 | Greene Barry E (President) | Option Ex | 11,844 | 12.88 | 152,550 |
| 2017-09-20 | Greene Barry E (President) | Sale | 76,815 | 100.00 | 7,681,500 |
| 2017-09-20 | Greene Barry E (President) | Option Ex | 76,815 | 31.39 | 2,411,222 |
| 2017-06-13 | Vaishnaw Akshay (EVP, R&D) | Option Ex | 1,668 | 20.00 | 33,368 |
| 2017-05-31 | Sanofi (10% Owner) | Buy | 297,501 | 71.87 | 21,381,396 |
| 2017-05-30 | Keating Laurie (SVP, GC and Secretary) | Buy | 11,500 | 65.35 | 751,502 |
| 2017-05-23 | Vaishnaw Akshay (EVP, R&D) | Sale | 11,000 | 75.00 | 825,000 |
| 2017-05-23 | Vaishnaw Akshay (EVP, R&D) | Option Ex | 11,000 | 21.35 | 234,850 |
| 2017-05-16 | Mason Michael (VP, Finance and Treasurer) | Sale | 9,375 | 70.00 | 656,250 |
| 2017-05-16 | Mason Michael (VP, Finance and Treasurer) | Option Ex | 9,375 | 12.88 | 120,750 |
| 2017-05-15 | Vaishnaw Akshay (SVP, R&D) | Sale | 43,750 | 65.00 | 2,843,750 |
| 2017-05-15 | Vaishnaw Akshay (SVP, R&D) | Option Ex | 43,750 | 26.37 | 1,153,687 |
| 2017-02-01 | Sharp Philip A (Director) | Sale | 25,000 | 39.94 | 998,500 |
| 2017-02-01 | Sharp Philip A (Director) | Option Ex | 25,000 | 31.29 | 782,250 |
| 2017-01-25 | Sharp Philip A (Director) | Sale | 15,000 | 37.95 | 569,250 |
| 2017-01-25 | Sharp Philip A (Director) | Option Ex | 15,000 | 31.39 | 470,850 |
| 2017-01-18 | Sharp Philip A (Director) | Sale | 15,000 | 37.88 | 568,275 |
| 2017-01-18 | Sharp Philip A (Director) | Option Ex | 15,000 | 15.91 | 238,650 |
| 2017-01-05 | Maraganore John (Chief Executive Officer) | Option Ex | 1,340 | 18.66 | 25,004 |
| 2016-12-30 | Vaishnaw Akshay (EVP, R&D) | Option Ex | 9,547 | 18.81 | 179,607 |
| 2016-12-12 | Maraganore John (Chief Executive Officer) | Option Ex | 30,151 | 22.75 | 685,935 |
| 2016-11-30 | Vaishnaw Akshay (EVP, R&D, CMO) | Sale | 29,165 | 45.34 | 1,322,457 |
| 2016-11-30 | Vaishnaw Akshay (EVP, R&D, CMO) | Option Ex | 29,165 | 22.75 | 663,503 |
| 2016-10-13 | Pyott David E I (Director) | Buy | 27,900 | 37.00 | 1,032,327 |
| 2016-10-12 | Maraganore John (Chief Executive Officer) | Option Ex | 7,540 | 12.88 | 97,115 |
| 2016-07-20 | Maraganore John (CEO) | Sale | 15,075 | 65.28 | 984,141 |
| 2016-07-20 | Maraganore John (CEO) | Option Ex | 15,075 | 22.75 | 342,956 |
| 2016-07-19 | Maraganore John (CEO) | Sale | 15,076 | 64.14 | 967,004 |
| 2016-07-19 | Maraganore John (CEO) | Option Ex | 15,076 | 22.75 | 342,979 |
| 2016-04-20 | Maraganore John (Chief Executive Officer) | Sale | 15,075 | 67.81 | 1,022,235 |
| 2016-04-20 | Maraganore John (Chief Executive Officer) | Option Ex | 15,075 | 22.75 | 342,956 |
| 2016-04-19 | Maraganore John (Chief Executive Officer) | Sale | 15,076 | 67.91 | 1,023,796 |
| 2016-04-19 | Maraganore John (Chief Executive Officer) | Option Ex | 15,076 | 22.75 | 342,979 |
| 2016-03-24 | Greene Barry E (President and COO) | Option Ex | 16,540 | 8.12 | 134,304 |
| 2016-03-09 | Bonney Michael W (Director) | Buy | 2,000 | 58.36 | 116,720 |
| 2016-02-01 | Sanofi (10% Owner) | Buy | 205,030 | 69.75 | 14,300,842 |
| 2016-01-20 | Maraganore John (Chief Executive Officer) | Sale | 15,076 | 70.50 | 1,062,903 |
| 2016-01-20 | Maraganore John (Chief Executive Officer) | Option Ex | 15,076 | 22.75 | 342,979 |
| 2016-01-19 | Maraganore John (Chief Executive Officer) | Sale | 15,076 | 74.49 | 1,122,966 |
| 2016-01-19 | Maraganore John (Chief Executive Officer) | Option Ex | 15,076 | 22.75 | 342,979 |
| 2015-12-04 | Sharp Philip A (Director) | Sale | 30,000 | 109.00 | 3,270,000 |
| 2015-12-04 | Sharp Philip A (Director) | Option Ex | 30,000 | 14.39 | 431,850 |
| 2015-12-02 | Maraganore John (Chief Executive Officer) | Sale | 58,689 | 104.99 | 6,161,523 |
| 2015-12-02 | Maraganore John (Chief Executive Officer) | Option Ex | 58,689 | 13.12 | 769,999 |
| 2015-11-25 | Vaishnaw Akshay (EVP, R&D, CMO) | Option Ex | 5,750 | 19.59 | 112,642 |
| 2015-11-20 | Maraganore John (Chief Executive Officer) | Sale | 58,690 | 103.14 | 6,053,580 |
| 2015-11-20 | Maraganore John (Chief Executive Officer) | Option Ex | 69,254 | 10.11 | 700,157 |
| 2015-11-12 | Starr Kevin P (Director) | Sale | 37,500 | 101.53 | 3,807,562 |
| 2015-11-12 | Starr Kevin P (Director) | Option Ex | 37,500 | 13.57 | 509,062 |
| 2015-11-11 | Starr Kevin P (Director) | Sale | 37,500 | 107.31 | 4,023,975 |
| 2015-11-11 | Starr Kevin P (Director) | Option Ex | 37,500 | 10.31 | 386,812 |
| 2015-08-04 | Greene Barry E (President and COO) | Option Ex | 26,972 | 19.03 | 513,277 |
| 2015-06-16 | Vaishnaw Akshay (EVP, R&D, CMO) | Sale | 8,750 | 129.49 | 1,132,993 |
| 2015-06-16 | Vaishnaw Akshay (EVP, R&D, CMO) | Option Ex | 8,750 | 8.20 | 71,750 |
| 2015-06-01 | Mason Michael (VP, Finance and Treasurer) | Sale | 4,791 | 131.89 | 631,884 |
| 2015-06-01 | Mason Michael (VP, Finance and Treasurer) | Option Ex | 4,791 | 49.99 | 239,526 |
| 2015-05-26 | Greene Barry E (President and COO) | Sale | 67,379 | 125.00 | 8,422,375 |
| 2015-05-26 | Greene Barry E (President and COO) | Option Ex | 67,379 | 13.12 | 884,012 |
| 2015-05-12 | Bonney Michael W (Director) | Buy | 2,000 | 112.16 | 224,320 |
| 2015-04-21 | Ausiello Dennis A (Director) | Sale | 8,165 | 130.02 | 1,061,613 |
| 2015-04-21 | Schimmel Paul (Director) | Sale | 10,000 | 130.02 | 1,300,200 |
| 2015-04-21 | Schimmel Paul (Director) | Option Ex | 10,000 | 28.68 | 286,850 |
| 2015-03-19 | Ausiello Dennis A (Director) | Sale | 5,000 | 120.00 | 600,000 |
| 2015-03-19 | Schimmel Paul (Director) | Sale | 9,053 | 120.00 | 1,086,360 |
| 2015-03-19 | Schimmel Paul (Director) | Option Ex | 9,053 | 27.28 | 246,965 |
| 2015-03-17 | Vaishnaw Akshay (EVP, R&D, CMO) | Sale | 8,750 | 117.30 | 1,026,410 |
| 2015-03-17 | Vaishnaw Akshay (EVP, R&D, CMO) | Option Ex | 8,750 | 8.20 | 71,750 |
| 2015-03-17 | Schimmel Paul (Director) | Sale | 947 | 120.00 | 113,640 |
| 2015-03-17 | Schimmel Paul (Director) | Option Ex | 947 | 27.28 | 25,834 |
| 2015-03-05 | Ausiello Dennis A (Director) | Sale | 706 | 115.00 | 81,190 |
| 2015-03-05 | Ausiello Dennis A (Director) | Option Ex | 706 | 63.86 | 45,085 |
| 2015-01-29 | Sanofi (10% Owner) | Buy | 97,118 | 95.00 | 9,226,210 |
| 2015-01-26 | Paul Steven M (Director) | Buy | 1,000 | 95.00 | 95,000 |
| 2015-01-26 | Maraganore John (Chief Executive Officer) | Buy | 10,000 | 95.00 | 950,000 |
| 2015-01-26 | Sanofi (10% Owner) | Buy | 647,448 | 95.00 | 61,507,560 |
| 2015-01-22 | Sanofi (10% Owner) | Buy | 196,251 | 9,317.00 | 1,828,470,567 |
| 2014-12-31 | Reid Laurence (SVP, Chief Business Officer) | Option Ex | 17,000 | 15.99 | 271,830 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALNY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alnylam Pharmaceuticals, Inc. (symbol ALNY, CIK number 1178670) see the Securities and Exchange Commission (SEC) website.